Zhou L, Beattie MC, Lin C-Y, Liu J, Traore K, Papadopoulos V, et al
Universities, biotechnology companies, pharmaceutical researchers, endocrinology laboratories, and authorised scientific institutions
About 20% of the relatives of pernicious anemia patients also have the condition, suggesting a genetic predisposition
Results Immediate improvements with continued settling over 12 weeks
Nrf2 expression was increased after deletion of MST1, whereas silencing of Nrf2 abolished the protective effects of Mst1 deletion on nasal epithelium survival and mitochondrial homeostasis (Song et al., 2019)
Human alpha class glutathione S -transferases: genetic polymorphism, expression, and susceptibility to disease